FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281727996> ?p ?o ?g. }

• W4281727996 endingPage "2843" @default.
• W4281727996 startingPage "2843" @default.
• W4281727996 abstract "Therapy-related acute myeloid leukemia (t-AML) and acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) represent aggressive diseases characterized by a dismal prognosis if compared with de novo acute myeloid leukemia, especially in older patients. In these AML subsets, standard chemotherapy regimens produce poor response rates and unsatisfactory outcomes. Historically, conventional approaches consisted of an anthracycline combined with continuous infusion of cytarabine for 7 days, the 3+7 regimen. Several attempts have been conducted to ameliorate this combination regimen but inconsistent improvements in response rates and no significant changes in overall survival have been observed, until the recent introduction of targeted molecules. A liposomal formulation of traditional chemotherapy agents cytarabine and daunorubicin, termed CPX-351, enhances pharmacodynamics and synergistic effects through the maintenance of the optimal 5:1 molar ratio, which extends the treatment's half-life and increases the bone marrow tropism of the drug. The use of CPX-351 in newly diagnosed AML-MRC and t-AML patients aged 60-75 years has demonstrated superior remission rates compared to conventional chemotherapy and improvements in event-free and overall survival. Recently, published data from a 5-year follow-up highlighted evidence that CPX-351 has the ability to produce and contribute to long-term remission and survival in older patients with newly diagnosed high-risk/secondary AML. Future perspectives include evaluation of dose intensification with CPX-351 in high-risk settings, combining this agent with targeted therapies, and better understanding the mechanism of improved responses in t-AML and AML-MRC. In this review, we will examine the role of CPX-351 inside the new AML therapeutic scenario and how its employment could potentially modify the treatment algorithm of high-risk and elderly patients with AML." @default.
• W4281727996 created "2022-06-13" @default.
• W4281727996 creator A5010335217 @default.
• W4281727996 creator A5024376231 @default.
• W4281727996 creator A5051164378 @default.
• W4281727996 creator A5055193194 @default.
• W4281727996 creator A5063661249 @default.
• W4281727996 creator A5086920822 @default.
• W4281727996 date "2022-06-08" @default.
• W4281727996 modified "2023-09-25" @default.
• W4281727996 title "CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML" @default.
• W4281727996 cites W1568498224 @default.
• W4281727996 cites W1969911820 @default.
• W4281727996 cites W1986993506 @default.
• W4281727996 cites W1994791499 @default.
• W4281727996 cites W1999705499 @default.
• W4281727996 cites W203809443 @default.
• W4281727996 cites W2041356430 @default.
• W4281727996 cites W2048517151 @default.
• W4281727996 cites W2055884944 @default.
• W4281727996 cites W2057051793 @default.
• W4281727996 cites W2076999892 @default.
• W4281727996 cites W2107027906 @default.
• W4281727996 cites W2123331484 @default.
• W4281727996 cites W2136112505 @default.
• W4281727996 cites W2147860795 @default.
• W4281727996 cites W2162351643 @default.
• W4281727996 cites W2167134612 @default.
• W4281727996 cites W2238408377 @default.
• W4281727996 cites W2339658711 @default.
• W4281727996 cites W2519204545 @default.
• W4281727996 cites W2558446569 @default.
• W4281727996 cites W2566711870 @default.
• W4281727996 cites W2601344701 @default.
• W4281727996 cites W2611657990 @default.
• W4281727996 cites W2738685991 @default.
• W4281727996 cites W2741997980 @default.
• W4281727996 cites W2758890913 @default.
• W4281727996 cites W2765254033 @default.
• W4281727996 cites W2790178918 @default.
• W4281727996 cites W2792113799 @default.
• W4281727996 cites W2807682826 @default.
• W4281727996 cites W2883399820 @default.
• W4281727996 cites W2889152482 @default.
• W4281727996 cites W2909182124 @default.
• W4281727996 cites W2912804762 @default.
• W4281727996 cites W2945230153 @default.
• W4281727996 cites W2946024019 @default.
• W4281727996 cites W2980824860 @default.
• W4281727996 cites W2985197312 @default.
• W4281727996 cites W2987093888 @default.
• W4281727996 cites W3022969666 @default.
• W4281727996 cites W3025300208 @default.
• W4281727996 cites W3046856303 @default.
• W4281727996 cites W3092027201 @default.
• W4281727996 cites W3096017746 @default.
• W4281727996 cites W3120624848 @default.
• W4281727996 cites W3126473107 @default.
• W4281727996 cites W3132370757 @default.
• W4281727996 cites W3176370909 @default.
• W4281727996 cites W3179177879 @default.
• W4281727996 cites W3203203901 @default.
• W4281727996 cites W3214589663 @default.
• W4281727996 cites W3217667247 @default.
• W4281727996 cites W4200542010 @default.
• W4281727996 cites W4231346141 @default.
• W4281727996 doi "https://doi.org/10.3390/cancers14122843" @default.
• W4281727996 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35740508" @default.
• W4281727996 hasPublicationYear "2022" @default.
• W4281727996 type Work @default.
• W4281727996 citedByCount "2" @default.
• W4281727996 countsByYear W42817279962022 @default.
• W4281727996 countsByYear W42817279962023 @default.
• W4281727996 crossrefType "journal-article" @default.
• W4281727996 hasAuthorship W4281727996A5010335217 @default.
• W4281727996 hasAuthorship W4281727996A5024376231 @default.
• W4281727996 hasAuthorship W4281727996A5051164378 @default.
• W4281727996 hasAuthorship W4281727996A5055193194 @default.
• W4281727996 hasAuthorship W4281727996A5063661249 @default.
• W4281727996 hasAuthorship W4281727996A5086920822 @default.
• W4281727996 hasBestOaLocation W42817279961 @default.
• W4281727996 hasConcept C121608353 @default.
• W4281727996 hasConcept C126322002 @default.
• W4281727996 hasConcept C143998085 @default.
• W4281727996 hasConcept C2776694085 @default.
• W4281727996 hasConcept C2776802502 @default.
• W4281727996 hasConcept C2778041864 @default.
• W4281727996 hasConcept C2778336483 @default.
• W4281727996 hasConcept C2778461978 @default.
• W4281727996 hasConcept C2778729363 @default.
• W4281727996 hasConcept C2781021840 @default.
• W4281727996 hasConcept C2781413609 @default.
• W4281727996 hasConcept C530470458 @default.
• W4281727996 hasConcept C71924100 @default.
• W4281727996 hasConceptScore W4281727996C121608353 @default.
• W4281727996 hasConceptScore W4281727996C126322002 @default.
• W4281727996 hasConceptScore W4281727996C143998085 @default.
• W4281727996 hasConceptScore W4281727996C2776694085 @default.

• next